28
Oct
2025
Linnea SA
Exhibitor at CPHI Frankfurt 2025 stand 9.1D78, Integrated Pharma
About Us
Categories
-
CH
-
2015On CPHI since
-
2Certificates
-
50 - 99Employees
Company types
Primary activities
Event information
CPHI Frankfurt 2025
-
28 Oct 2025 - 30 Oct 2025
-
Messe, Frankfurt
-
Visit us at stand 9.1D78, Integrated Pharma
Products Featured at CPHI Frankfurt 2025
-
Product Red Clover
Linnea’s Red Clover botanical extract is extracted using a unique formula, balancing the main four Red Clover isoflavones,consistent through every batch. Linnea thus ensures consistent quality and standardization of Red Clover. -
Product Vincamine
Vincamine is a semi-synthetic derivative, extracted using a proprietary methodto Linnea, vetted to GMP-standard quality controls, obtaining a state-of-theartproduct. Vincamine is CEP certified, and complies with Ph.Eur. monograph“Vincamine”, that Linnea developed. -
Product Vinpocetine
Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified. -
Product Butylscopolamine
Linnea’s Vinpocetine is a semi-synthetic derivative, extracted using a provenmethod, vetted with in-house GMP-standard quality controls, resulting in ahigh-quality profile and outstanding therapeutic value end product. Linnea’sVinpocetine is compliant with the European Pharmacopoeia and is CEP certified. -
Product Cannabinoids
A treasure trove of active ingredients just waiting to be rediscovered. Linnea’s therapeutic Cannabinoid solutions are the culmination of more than four decades of experience and unrivaled attention to quality. Linnea' CBD is compliant with the new Ph. Eur. Monograph. -
Product 5 HTP
5-hydroxytryptophan is an amino-acid with nootropic and antidepressant actions,naturally present in the brain and found in food in small doses. Exogenous therapeutic 5 HTP is isolated from the seeds of the African plant Griffonia simplicifolia. -
Product Bilberry
Grown in forests in Northern Europe, our antioxidant-rich bilberries are transformed into GMP certified and approved dry extracts. -
Product Ginkgo biloba
Linnea’s Ginkgo Biloba dry extract is derived in two different methods, allowing to obtain two different products, Ginkgo Biloba EPG 246, and Ginkgo Biloba Ethanol,suitable for pharmaceutical and food applications respectively, with comparable activity. Linnea's Ginkgo Biloba complies with the current edit... -
Product HMRlignan®
HMRlignan® is extracted from the Picea abies L. (Norway Spruce) plant.The raw material is harvested in a sustainable way, working with local forestry commissions and authorities. Linnea has a special extraction method and its HMRlignan® has a unique activity as a result.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance